Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy).
Saved in:
| Title: | Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy). |
|---|---|
| Authors: | Scullion, Kathleen M1 (AUTHOR), MacIntyre, Iain M1 (AUTHOR), Sloan-Dennison, Sian2 (AUTHOR), Clark, Benjamin2 (AUTHOR), Fineran, Paul3 (AUTHOR), Mair, Joanne3 (AUTHOR), Creasey, David4 (AUTHOR), Rathmell, Cicely4 (AUTHOR), Faulds, Karen2 (AUTHOR), Graham, Duncan2 (AUTHOR), Webb, David J1 (AUTHOR), Dear, James W1,5 (AUTHOR) james.dear@ed.ac.uk |
| Source: | Toxicological Sciences. Jun2024, Vol. 199 Issue 2, p203-209. 7p. |
| Database: | Environment Complete |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
